SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
Annals of Clinical and Translational Neurology · 2026
DOI: 10.1002/acn3.70211 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Nuria Muelas und 18 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Diseases Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Muscular Dystrophies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Isabel Gemio, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas.
Abstract (Originalsprache)
Objective
SNUPN ‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described. Here we report the first family with SNUPN ‐related muscular dystrophy presenting an adult‐onset myopathy as well as novel ultrastructural findings.
Methods
Clinical evaluation, muscle and brain magnetic resonance imaging (MRI), and muscle histopathological and electron microscopy analysis were conducted. Functional studies including protein modelling and interaction, immunofluorescence and splicing analysis were also performed.
Results
Two siblings carrying two novel deleterious variants in the SNUPN gene (p.Arg27Cys and p.Cys174Tyr) showed adult‐onset proximo‐distal and axial muscle weakness with early respiratory involvement. One patient presented with asymptomatic cerebellar atrophy. Muscle MRI identified involvement in the paravertebral, triceps brachii, sartorius and gracilis muscles. The histopathology revealed dystrophic changes and an abnormal pattern of cytoskeletal and myofibrillar proteins, while electron microscopy disclosed the proliferation of granules and vesicles associated with features of nuclear envelope and sarcolemma remodelling. Functional studies showed that SNUPN variants impair snurportin‐1 function through reduced binding affinity to importin‐β and impaired folding, leading to disturbed nuclear import of small nuclear ribonucleoproteins and downstream splicing.
Interpretation
Our work expands the phenotype of SNUPN ‐related muscular dystrophy and provides more insights into their pathological profile. We advise SNUPN testing in patients with late‐onset proximo‐distal and axial weakness with early respiratory impairment and features reminding inclusion body myositis (IBM). Granular deposits suggestive of biomolecular condensates perturbed cell organelle traffic and membrane homeostasis, opening new avenues to understand the pathomechanisms involved in this novel disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuromuscular Diseases Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- Department of Medicine, Universitat de València, Valencia, Spain.
- Department of Neurosciences, Biogipuzkoa Health Research Institute, San Sebastián, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Sonia Alonso-Martín, Lorea Blázquez
Förderung
- Fundación Isabel Gemio
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Eusko Jaurlaritza
- Ministerio de Ciencia y Tecnología, Gobierno de España
- NIHR Newcastle Biomedical Research Centre
- Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER)
- Agencia Estatal de Investigación
Zitieren
APA
Muelas, N., Iruzubieta, P., Damborenea, A., Pérez-Fernández, L., Azorín, I., Jiménez García, J. C., Töpf, A., Martí, P., Fores-Toribio, L., Manterola, M., Blanco-Mañez, R., Pikatza-Menoio, O., Alonso-Martín, S., Straub, V., Cortajarena, A. L., López de Munain, A., De Sancho, D., Blázquez, L., & Vilchez, J. J. (2026). SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70211
Vancouver
Muelas N, Iruzubieta P, Damborenea A, Pérez-Fernández L, Azorín I, Jiménez García JC, et al. SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70211
BibTeX
@article{Muelas2026,
author = {Muelas, Nuria and Iruzubieta, Pablo and Damborenea, Alberto and Pérez-Fernández, Laura and Azorín, Inmaculada and Jiménez García, Juan Carlos and Töpf, Ana and Martí, Pilar and Fores-Toribio, Lorena and Manterola, María and Blanco-Mañez, Rosana and Pikatza-Menoio, Oihane and Alonso-Martín, Sonia and Straub, Volker and Cortajarena, Aitziber L and López de Munain, Adolfo and De Sancho, David and Blázquez, Lorea and Vilchez, Juan J},
title = {SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70211}
}
EUVIMED